Evaluation of Electrocardiogram Parameters and Heart Rate Variability During Blood Pressure Elevation by Phenylephrine in Cirrhotic Rats.

[1]  Hongqun Liu,et al.  Dysregulated Calcium Handling in Cirrhotic Cardiomyopathy , 2023, Biomedicines.

[2]  D. Dadhania,et al.  Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice‐based recommendations , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  Hyunsu Kang.  Sample size determination and power analysis using the G*Power software , 2021, Journal of educational evaluation for health professions.

[4]  F. Ketabchi,et al.  Heart rate variability and pulmonary dysfunction in rats subjected to hemorrhagic shock , 2020, BMC Cardiovascular Disorders.

[5]  F. Ketabchi,et al.  Roles of glutamate and GABA of the Kölliker-Fuse nucleus in generating the cardiovascular chemoreflex , 2020, Pflügers Archiv - European Journal of Physiology.

[6]  A. Porta,et al.  Concomitant Evaluation of Heart Period and QT Interval Variability Spectral Markers to Typify Cardiac Control in Humans and Rats , 2019, Front. Physiol..

[7]  F. Ketabchi,et al.  Impact of liver damage on blood-borne variables and pulmonary hemodynamic responses to hypoxia and hyperoxia in anesthetized rats , 2019, BMC Cardiovascular Disorders.

[8]  Samuel S. Lee,et al.  Cirrhotic cardiomyopathy. , 2018, Journal of hepatology.

[9]  K. Wodack,et al.  Assessment of central hemodynamic effects of phenylephrine: an animal experiment , 2018, Journal of Clinical Monitoring and Computing.

[10]  F. Bendtsen,et al.  The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[11]  F. Shaffer,et al.  An Overview of Heart Rate Variability Metrics and Norms , 2017, Front. Public Health.

[12]  C. Bergamaschi,et al.  Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats , 2016, PloS one.

[13]  A. Abbate,et al.  Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase. , 2016, Journal of cardiology.

[14]  E. Omerovic,et al.  Different catecholamines induce different patterns of takotsubo-like cardiac dysfunction in an apparently afterload dependent manner. , 2014, International journal of cardiology.

[15]  Y. Maehara,et al.  Management of thrombocytopenia due to liver cirrhosis: a review. , 2014, World journal of gastroenterology.

[16]  A. Eroğlu.  The Effect of Intravenous Anesthetics on Ischemia-Reperfusion Injury , 2014, BioMed research international.

[17]  F. Bendtsen,et al.  Cardiac sympathetic imaging with mIBG in cirrhosis and portal hypertension: relation to autonomic and cardiac function. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[18]  H. Niwa,et al.  Autonomic and cardiovascular effects of pentobarbital anesthesia during trigeminal stimulation in cats , 2012, International Journal of Oral Science.

[19]  J. Bermejo,et al.  The heart in liver transplantation. , 2011, Journal of hepatology.

[20]  J. Klimas,et al.  Heart rate correction of the QT duration in rats. , 2010, European journal of pharmacology.

[21]  M. Taylor,et al.  Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis , 2010, Hepatology.

[22]  G. Gores,et al.  Cellular and molecular mechanisms of liver injury. , 2008, Gastroenterology.

[23]  Z. Goodman.  Grading and staging systems for inflammation and fibrosis in chronic liver diseases. , 2007, Journal of hepatology.

[24]  Bulent Yildirim,et al.  The Relationship of Heart Rate Variability with Severity and Prognosis of Cirrhosis , 2006, Digestive Diseases and Sciences.

[25]  G. Hwang,et al.  Assessment of Cardiovascular Autonomic Function in Patients with Liver Cirrhosis Using Heart Rate Variability, Blood Pressure Variability and Baroreflex Sensitivity , 2006 .

[26]  Samuel S. Lee,et al.  Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. , 2006, World journal of gastroenterology.

[27]  R. Groszmann,et al.  The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule , 2006, Hepatology.

[28]  E. Christensen,et al.  Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease , 2003, Gut.

[29]  R. Moreau,et al.  Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. , 2001, American journal of respiratory and critical care medicine.

[30]  J. Henriksen,et al.  High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems , 2001, Gut.

[31]  M. Contin,et al.  Q‐T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors , 1998, Hepatology.

[32]  J. Marty,et al.  Desensitization of myocardial β‐adrenergic receptors in cirrhotic rats , 1990 .

[33]  D. Lebrec,et al.  Alterations in isoprenaline sensitivity in patients with cirrhosis: evidence of abnormality of the sympathetic nervous activity. , 1986, British journal of clinical pharmacology.

[34]  F. Ketabchi,et al.  The Relationship between Liver Dysfunction, Electrocardiographic Abnormalities and Metabolism in Rat , 2018 .

[35]  Samuel S. Lee,et al.  Cardiac dysfunction in cirrhosis. , 2007, Best practice & research. Clinical gastroenterology.

[36]  A. Evangelista,et al.  Cardiac alterations in cirrhosis: reversibility after liver transplantation. , 2005, Journal of hepatology.